Navigation Links
Poor Physician Understanding of Drug-Coated-Balloon Mechanics Affects Perceived Effectiveness and Limits Adoption in Peripheral Vascular Treatment
Date:9/11/2013

TORONTO, Sept. 11, 2013 /PRNewswire/ -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, physicians who use drug-coated balloons (DCB), also known as drug-eluting balloons (DEB), to treat peripheral artery disease, particularly in the lower extremities, lack awareness of some aspects of DCB function, which limits perceived effectiveness and inhibits wider adoption of these devices.

(Logo: http://photos.prnewswire.com/prnh/20130103/MM36768LOGO )

For example, predilation is considered to have an important influence on DCB procedure efficacy. If the vessel is not predilated, some of the drug will be lost upon delivery to the lesion site. MRG's survey, however, shows vascular surgeons predilate in fewer than half of the lesions they treat with DCB. Of the total number of physicians surveyed, 10 percent never predilate at all. This modest use of predilation may result in poorer clinical outcomes, and thus influence physician perception of the efficacy of DCB treatment.

Physician opinions differed significantly on how long it takes a drug to diffuse through an artery wall, and how long the drug would remain in the deeper cell layers of the vessel wall. Knowledge of the actual speed and duration was limited. Both of these also affect their perceptions of the efficacy of a given device.

"There is clearly room for more robust clinical evidence and improved physician education on the mechanism of action for DCB," said Product Manager Stephanie LaBelle. "Manufacturers who are able to establish more clear evidence regarding the speed of drug diffusion and the duration of the drug in the vessel wall would boost physician confidence in DCB efficacy and increase adoption."

The results come from a new MRG report, The Use of Drug-Coated Balloons in Peripheral Vascular Interventions (Europe), part of its Physician Forum series. Physician Forum survey reports are produced in response to specific market events and trends that are expected to have significant effects on utilization and sales of medical devices. The survey report is now available.

The results are based on surveys that were conducted in June 2013 and included 200 physicians. Survey respondents were interventional cardiologists, interventional radiologists and vascular surgeons, with a total of 40 physicians each from France, Germany, Italy, Spain and the United Kingdom.

Millennium Research Group's The Use of Drug-Coated Balloons in Peripheral Vascular Interventions (Europe) survey report provides information about current and future clinical applications for DCBs as well as physician perceptions of the various DCB brands.

About Millennium Research Group
Millennium Research Group (www.MRG.net), a Decision Resources Group company (www.DecisionResourcesGroup.com), is the global authority on medical technology market intelligence and the leading provider of strategic information to the healthcare sector. The company provides specialized industry expertise through multiclient market research, ongoing Marketrack™ projects, customer loyalty tracking, facility-level procedure forecasting, and customized solutions.

About Decision Resources Group
Decision Resources Group is a cohesive portfolio of companies that offers best-in-class, high-value information, and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources Group at www.DecisionResourcesGroup.com.

All company, brand or product names contained in this document may be trademarks or registered trademarks of their respective holders.For more information, contact:Christopher Comfort

Alex JablokowDecision Resources Group

Millennium Research Group781-993-2597

781-993-2517ccomfort@dresources.com

ajablokow@mrg.net


'/>"/>
SOURCE Millennium Research Group
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Doximity Medical Network Grows to 200,000 Physician Members
2. PRN Physician Recommended Nutriceuticals Selected for the Second Consecutive Year to the Inc. 500
3. 5000 List of Fastest-Growing Privately Held Companies
4. Senator Shares Insight on Florida Physician Dispensing Legislation as First Guest of Progressive Medicals New SignatureSeries
5. Physicians Practice Wins Multiple Awards for Digital and Print Excellence
6. Orange County Physician Owned Medical Group Opens Pioneering Medical Facility
7. Physicians Expect More Out of Tablet-Toting Pharmaceutical Sales Reps, Study Finds
8. Recent Study Reveals Physicians Prefer Topical Delivery for Drug Delivery Technology, Such as a Transdermal Patch
9. Parents May Have Even More Reason to Explore Weight Loss Surgery, suggests Beverly Hills Physicians
10. After Reviewing Brief Product Profiles, Surveyed Physicians Believe that Likely Candidates for Late-Phase Chronic Kidney Disease Products from AbbVie, Mitsubishi Tanabe, Eli Lilly, Concert, Fibrogen and Pfizer are Typically Stage 3b and 4 Patients
11. Patients and Physicians Express Desire to Switch to Transdermal Drug Delivery, Finds Frost & Sullivan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... INDIANAPOLIS , Feb. 11, 2016  Attending college ... for those with type 1 diabetes, the journey can ... class schedules, assignments and campus activities, they also manage ... On top of that, many are living away from ... Foundation (Foundation) Lilly Diabetes Tomorrow,s Leaders Scholarship with ...
(Date:2/11/2016)... ALBANY, New York , February 11, 2016 ... Research announces the release of a new research report, titled ... Growth, Trends and Forecast, 2013 - 2019". According to the ... expand at a 4.40% CAGR from 2013 to 2019, growing ... bn by 2019. --> --> ...
(Date:2/11/2016)... ROCKLEDGE, Fla. , Feb. 11, 2016 ... have started out 2016 with sales exceeding company targets, ... and have received their trademark from the United States ... Bobby Clark , Chief Executive Officer of PLAD, ... state of Pennsylvania with two ...
Breaking Medicine Technology:
(Date:2/11/2016)... ... February 11, 2016 , ... Pediatric ... to improve care by making data on heart procedures public and easily understandable ... Transparency and Public Reporting of Pediatric and Congenital Heart Disease Outcomes will bring ...
(Date:2/11/2016)... ... ... In a new paper published in the latest issue ... Rohrich, and colleagues, examine and underscore the importance of upper lateral cartilage in ... this vital area. , The upper lateral cartilage in rhinoplasty, refers to a ...
(Date:2/11/2016)... ... February 11, 2016 , ... veEDIS Clinical Systems, LLC, announced ... adaptable algorithms, has been updated to help Emergency Department physicians and nurses identify ... Zikas and a travel history to affected regions, or potential exposure through another, ...
(Date:2/11/2016)... ... February 11, 2016 , ... "What holds you back from ... poses a question as a challenge for his readers to examine the full ... Being" (published by Partridge Singapore), Clarke explores the subject with more depth, revealing ...
(Date:2/11/2016)... (PRWEB) , ... February 11, 2016 , ... Life is ... group of men, 60 and older, who gather once a year to play softball ... a love for the game, the more than 50 players who competed in this ...
Breaking Medicine News(10 mins):